Castle Biosciences Inc. (CSTL) Misses Q3 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to Castle Biosciences Inc. (CSTL) Misses Q3 EPS by 7c

Castle Biosciences Announces Third Quarter 2021 Results

November 8, 2021 4:05 PM EST

Q3 2021 revenue grew by 54% over the prior year quarter to $23.5 million
Q3 2021 total dermatology test report volume of 7,352
On track to achieve 2021 total revenue guidance of $89-93 million
Conference call and webcast today at 4:30 p.m. ET

FRIENDSWOOD, Texas--(BUSINESS WIRE)-- Castle Biosciences, Inc. (Nasdaq: CSTL), a company applying innovative diagnostics to inform disease management and improve patient outcomes, today announced its financial results for the third quarter and nine months ended Sept. 30, 2021.

The Castle team achieved another quarter of strong growth in revenue and... More